淋巴血管系统在细胞外囊介导瘤进展中的淋巴血管系统
Pragati Lodha1,2,3, Alperen Acari1,2,3, Jochen Rieck1,2
1European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Cancers
|December 17, 2024
概括
来自瘤的细胞外囊泡 (EVs) 通过淋巴系统传播,影响免疫逃生和转移. 了解这种途径是开发新癌症疗法的关键.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 血管生物学 血管生物学
背景情况:
- 瘤生长涉及复杂的细胞相互作用.
- 细胞外囊泡 (EVs) 介导癌细胞和宿主细胞之间的分子通信.
- 通过改变受体细胞功能,EVs可以促进瘤免疫逃逸和转移.
研究的目的:
- 突出淋巴血管系统在瘤细胞衍生的EVs的分布和进展促进功能中的关键作用.
- 强调瘤排水淋巴结作为EV介导效应的关键部位.
- 强调需要对EV传输和在淋巴系统内的相互作用有机学的理解,以便进行治疗.
主要方法:
- 关于细胞外囊泡 (EV) 运输的最新研究的综述和综合.
- 专注于淋巴血管系统在固体瘤中EV分布中的作用.
- 对EV相互作用在瘤排水淋巴结内及其他地方的分析.
主要成果:
- 淋巴血管系统是瘤衍生的EVs的区域和系统分布的主要途径.
- 瘤排水淋巴结是EVs发挥作用的关键部位.
- EVs有助于形成前转移性,促进瘤扩散.
结论:
- 淋巴系统对于瘤衍生的EVs的传播和随后的瘤进展至关重要.
- 针对淋巴系统内的EV运输或相互作用提供了潜在的治疗策略.
- 对EV淋巴吸收和功能机制的进一步研究对于新型癌症治疗至关重要.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Intralumenal Vesicles and Multivesicular Bodies
3.4K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K


